The comparison of weekly and 3-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic SCCHN

被引：0
|
作者：
Uygun, Kazim
Karagol, Hakan
Caloglu, Murat
Cicin, Irfan
Caloglu, Vuslat Y.
Uzunoglu, Sernaz
Saip, Pinar
机构：
[1] Trakya Univ, Fac Med, Edirne, Turkey
[2] Trakya Univ, Fac Med, Edirne, Turkey
[3] Istanbul Univ, Inst Oncol, Istanbul, Turkey
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [1] The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck
    Uygun, Kazim
    Bilici, Ahmet
    Karagol, Hakan
    Caloglu, Murat
    Cicin, Irfan
    Aksu, Gorkem
    Fayda, Merdan
    Uzunoglu, Sernaz
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (03) : 601 - 605
  • [2] The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck
    Kazim Uygun
    Ahmet Bilici
    Hakan Karagol
    Murat Caloglu
    Irfan Cicin
    Gorkem Aksu
    Merdan Fayda
    Sernaz Uzunoglu
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 601 - 605
  • [3] THE COMPARATIVE EVALUATION OF RADIOTHERAPY WITH CONCURRENT WEEKLY CISPLATIN VERSUS CONCURRENT 3-WEEKLY CISPLATIN AND ETOPOSIDE IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED NON SMALL CELL LUNG CANCER
    Bagri, P. K.
    Hirapara, P.
    Kapoor, A.
    Singhal, M.
    Singh, D.
    Jakhar, S. L.
    Beniwal, S. K.
    Sharma, N.
    Kumar, H.
    Sharma, A.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S35 - S36
  • [4] Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer
    Espeli, V.
    Zucca, E.
    Ghielmini, M.
    Giannini, O.
    Salatino, A.
    Martucci, F.
    Richetti, A.
    ORAL ONCOLOGY, 2012, 48 (03) : 266 - 271
  • [5] A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer
    Oosting, S. F.
    Chen, T. W. W.
    Huang, S. H. H.
    Wang, L.
    Waldron, J.
    Gilbert, R.
    Goldstein, D. P.
    Halmos, G. B.
    Witjes, M. J. H.
    Gietema, J. A.
    O'Sullivan, B.
    Langendijk, J. A.
    Siu, L. L.
    Hansen, A. R.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S577 - S577
  • [6] A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer
    Oosting, Sjoukje F.
    Chen, Tom W. W.
    Huang, Shao H.
    Wang, Lisa
    Waldron, John
    Gilbert, Ralph
    Goldstein, David
    Halmos, Gyorgy B.
    Witjes, Max J. H.
    Gietema, Jourik A.
    O'Sullivan, Brian
    Langendijk, Johannes A.
    Siu, Lillian L.
    Hansen, Aaron R.
    ORAL ONCOLOGY, 2016, 59 : 43 - 49
  • [7] Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer.
    Espeli, V.
    Zucca, E.
    Ghielmini, M. E. G.
    Richetti, A.
    Giannini, O.
    Martucci, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck - a multicentre, retrospective analysis
    Helfenstein, Seth
    Riesterer, Oliver
    Meier, Urs R.
    Papachristofilou, Alexandros
    Kasenda, Benjamin
    Pless, Miklos
    Rothschild, Sacha I.
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [9] 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis
    Seth Helfenstein
    Oliver Riesterer
    Urs R. Meier
    Alexandros Papachristofilou
    Benjamin Kasenda
    Miklos Pless
    Sacha I. Rothschild
    Radiation Oncology, 14
  • [10] Comparison of 2-Weekly and 3-Weekly Dosing of Docetaxel in Metastatic Prostate Cancer
    Martinez-Recio, Sergio
    Perez-Wert, Juan Pablo
    Martinez-Fdez, Sara
    Jimenez-Bou, Diego
    Ruiz-Gutierrez, Iciar
    Pena, Jesus
    Pertejo, Ana
    Espinosa, Enrique
    Pinto, Alvaro
    CLINICAL GENITOURINARY CANCER, 2022, 20 (04) : 363 - 370
12345